Nashik Neuroscience Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 14-12-2024
- Paid Up Capital ₹ 1.76 M
as on 14-12-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 Cr
as on 14-12-2024
- Revenue -16.14%
(FY 2023)
- Profit -53.90%
(FY 2023)
- Ebitda -31.65%
(FY 2023)
- Net Worth 91.17%
(FY 2023)
- Total Assets 6.75%
(FY 2023)
About Nashik Neuroscience
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.76 M.
The company currently has active open charges totaling ₹3.00 Cr.
Sandeep Pangavane, Rahul Baviskar, Rahul Modgi, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85300MH2020PTC343889
- Company No.
343889
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nashik Neuroscience?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Pangavane  | Whole-Time Director | 07-Dec-2022 | Current |
| Rahul Baviskar | Director | 14-Aug-2020 | Current |
| Rahul Modgi | Whole-Time Director | 07-Dec-2022 | Current |
| Nahush Patil | Whole-Time Director | 07-Dec-2022 | Current |
| Dayananda Lindadhalli | Director | 14-Aug-2020 | Current |
| Sanjeev Desai | Whole-Time Director | 31-Dec-2021 | Current |
Financial Performance of Nashik Neuroscience.
Nashik Neuroscience Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.14% decrease. The company also saw a substantial fall in profitability, with a 53.9% decrease in profit. The company's net worth Soared by an impressive increase of 91.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nashik Neuroscience?
Unlock access to Nashik Neuroscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
City Care Hospital And Research Centre Private LimitedActive 23 years 10 monthsSandeep Pangavane is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Nov 2023 | ₹3.00 Cr | Open |
How Many Employees Work at Nashik Neuroscience?
Unlock and access historical data on people associated with Nashik Neuroscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nashik Neuroscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nashik Neuroscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
